Stage I
The treatment of chronic lymphocytic leukemia stage I can include the following:
- Make careful observations when the number of symptoms is low or no symptoms.
- Chemotherapy with one or more drugs, with or without steroids.
- Low doses of external radiation in areas of the body affected by cancer, such as the spleen or lymph nodes.
- A clinical trial with monoclonal antibodies.
- A clinical trial of chemotherapy and transplantation of primary cells.

Stage II
The treatment of chronic lymphocytic leukemia stage II can include the following:
- Make careful observations when symptoms are scarce or nonexistent.
- Chemotherapy with one or more drugs, with or without steroids.
- Low doses of external radiation in areas of the body affected by cancer, such as the spleen or lymph nodes.
- Radiation therapy to the spleen as palliative therapy to relieve symptoms and improve quality of life.
- A clinical trial with monoclonal antibodies.
- A clinical trial of chemotherapy and transplantation of primary cells.

Stage III
The treatment of chronic lymphocytic leukemia, stage III may include:
- Make careful observations when the presenting symptoms are scarce or nonexistent.
- Chemotherapy with one or more drugs, with or without steroids.
- Splenectomy (removal of the spleen).
- Low doses of external radiation in areas of the body where the cancer as the spleen or lymph nodes.
- Radiation therapy to the spleen as palliative therapy to relieve symptoms and improve quality of life.
- A clinical trial monoclonales.Un antibody with chemotherapy and transplantation of primary cells.

Stage IV
The treatment of chronic lymphocytic leukemia, stage IV may include the following:
- Make careful observations.
- Chemotherapy with one or more drugs, with or without steroids.
- Splenectomy.
- Radiation therapy to the spleen as palliative therapy to relieve symptoms and improve quality of life.
- A clinical trial with monoclonal antibodies.
- A clinical trial of chemotherapy and transplantation of primary cells.

Refractory
Treatment of refractory chronic lymphocytic leukemia may include the following:
- A clinical trial of chemotherapy and transplantation of primary cells.
- A clinical trial of a new treatment.

Incoming search terms for the article:

A part of this development the scientists say, or also give rise to blood cells do not like liver and other similar to neurons and other brain cells. However, scientists who have worked with adult stem cells continue to face major obstacles. These cells are scarce and difficult to recognize, but at least, any medical benefits that may not be reporting at the expense of the destruction of human embryos.
In addition to adult stem cells and embryonic stem cells have also been isolated embryonic germ cells. This type of stem cell derived from the gonadal ridge cells from embryos or fetuses, which produce eggs or sperm (the gonadal ridge turns into the ovaries or testes). Although embryonic germ stem cells differ from embryonic stem cells in many respects. Both institutions and others are pluripotent, ie able to generate almost all types of human cells. This potential becomes a very attractive candidate both in the creation of medical treatment without appropriate. As taken from embryos or aborted fetuses, their preparation requires the destruction of the embryo or fetus.

Have identified some risk of regenerative medicine and in the case lies in the rejection of foreign tissue by the patient’s immune system, one of the current solutions is to administer powerful drugs that suppress the immune system, but such substances have grave side effects. Another possibility would be to use stem cells taken from the patient’s own tissue as in the above case of childhood acute lymphocytic leukemia.

The solution that some scientists have proposed for the problem of immune rejection is to clone the patients, but only allow the clone to develop to the blastocyst stage, when you can extract embryonic stem cells in regenerative medicine must first discover how the body does not reject them.

It is not known why this increase in B cells and there is no link to radiation, chemical carcinogens or viruses.

Chronic lymphocytic leukemia mainly affects adults. The average age of a patient with this type of leukemia is 70 years and is rarely seen in people younger than 40 years. The disease is more common in Jews of Russian or Eastern Europe and is rare in Asians.

Here is a considerable amount of Auer rods, which are only found in acute myeloid leukemia’s, either myeloblastic or monoblastic. These rods consist of clumps of azurophilic granules.

Different types of treatment available for patients with chronic lymphocytic leukemia. Some treatments are standard (the currently used treatment) and some are being tested in clinical trials. Before starting treatment, patients should consider participating in a clinical trial.

A treatment clinical trial is a research study designed to improve current treatments or obtain information on new treatments for cancer patients. When clinical trials show that a new treatment is better than treatment “standard”, the new treatment may become standard.

There are four types of standard treatment:
- Make careful observations
Careful observation is the rigorous monitoring of a patient’s condition without giving any treatment until they appear or change the symptoms. It is also called observation. During this period, deal with problems caused by the disease, such as infection.

- Radiotherapy
Radiation therapy is a cancer treatment that uses high energy X-rays or other radiation to kill cancer cells. There are two types of radiation therapy. External radiation therapy uses a machine outside the body to send radiation toward the cancer.

Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer. The method of administration of radiation therapy depends on the type and stage of cancer treatment.

- Chemotherapy
Chemotherapy is a cancer treatment that uses drugs to stop the proliferation of cancer cells by eliminating or preventing cell division. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can affect cancer cells throughout the body (systemic chemotherapy).

When chemotherapy is placed directly into the spine, a body cavity such as the abdomen, or an organ, the drugs mainly affect cancer cells in those areas. The method of administration of radiation therapy depends on the type and stage of cancer treatment.

- Surgery
Splenectomy is surgery to remove the spleen.

Other types of treatment are being tested in clinical trials and include the following:
- Monoclonal Antibody Therapy
Monoclonal antibody therapy is a cancer treatment that uses antibodies made in the laboratory from a single type of immune system cells. These antibodies can identify substances on cancer cells or normal substances in the body that contribute to the growth of cancer cells.

The antibodies attach to the substances and kill cancer cells or block their growth. Monoclonal antibodies are given by infusion. They can be used alone or to deliver drugs, toxins or radioactive material directly into cancer cells.

- Chemotherapy with stem cells transplantation
The primary cell transplant is a method of giving chemotherapy and replacing blood-producing cells destroyed by cancer treatment. Cells are removed (immature blood cells) from blood or bone marrow of the patient or a donor and are frozen and stored.

At the end of primary chemotherapy stored cells are thawed and returned to the patient through an infusion. Over time, these primary cells returned to the body grow into (restore) in the cells of the body.

Incoming search terms for the article: